Table 1.
Baseline characteristics for 517 total patients receiving SAGB implant
| Characteristic | Value |
|---|---|
| Gender | |
| Male, N (%) | 61 (11.8) |
| Female, N (%) | 455 (88.01) |
| Age, mean ± SD, years (80 % IPR) | 37.5 ± 10.9 (23.4 to 53.7) |
| Duration of obesity, mean ± SD, years (80 % IPR) | 15.3 ± 8.4 (6.0 to 28.0) |
| Height, mean ± SD, m (80 % IPR) | 1.7 ± 0.1 (1.6 to 1.8) |
| Absolute weight, mean ± SD, kg (80 % IPR) | 111.4 ± 16.8 (93.0 to 133.0) |
| Excess body weight, mean ± SD, kg (80 % IPR) | 52.1 ± 14.1 (37.8 to 71.0) |
| BMI, mean ± SD, kg/m2 (80 % IPR) | 41.0 ± 4.9 (36.1 to 47.3) |
| BMI ≥40, kg/m2, N (%) | 291 (56.3) |
| BMI ≥35 and < 40, kg/m2, N (%) | 193 (37.3) |
| BMI <35, kg/m2, N (%) | 29 (5.6) |
| At least 1 comorbidity, N (%) | 384 (74.3) |
| History of family obesity, N (%) | 343 (66.3) |
| 1-year specialized medical care and multidisciplinary assessment, N (%) | 475 (91.9) |
| First bariatric intervention, N (%) | 471 (91.1) |
| Preoperative psychological evaluation, N (%) | 503 (97.3) |
| BAROSa, mean ± SD (80 % IPR) | 1.4 ± 1.4 (−0.3 to 3.0) |
| EQ-5Db, mean ± SD (80 % IPR) | 0.61 ± 0.31 (0.09 to 0.88) |
| EQ–VASc, mean ± SD (80 % IPR) | 52.3 ± 18.4 (30.0 to 80.0) |
SD standard deviation, IPR interpercentile range (the 80th IPR indicates variable values ranging from 10th to 90th percentile), BMI body mass index, BAROS Bariatric Analysis and Reporting Outcome System, EQ-5D EuroQoL 5-Dimensions, EQ–VAS EuroQoL-Visual Analog Scale
a N = 302 for BAROS data recorded at 30 days postoperative
b N = 449 with EQ-5D data at inclusion
c N = 446 with EQ–VAS data at inclusion